QurCan Therapeutics Inc.

📍 Toronto, Canada🗓 Founded 2018👥 7 employees💰 Last funded Apr 2021
QurCan Therapeutics (formerly Nanology Labs Inc) is a biotechnology company using advanced nanoparticle drug-delivery technology to unleash the immense potential of next-generation biological and genetic medicine and deliver life-changing therapeutics. QurCans next generation nanoparticle platform, TERP, enables tissue-selective delivery of nucleotides and biological therapeutics to extra-hepatic sites, including brain and spleen. TERP technology is a breakthrough technology with the great potential to deliver a new era of disease-modifying genetic medicine that will make a difference to patients with a wide range of unmet medical needs.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2018
Founded
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in QurCan Therapeutics Inc.?
QurCan Therapeutics Inc. has 1 investors on record on gritt.io, 1 mid-stage.
When did QurCan Therapeutics Inc. last raise funding?
The most recent investment in QurCan Therapeutics Inc. recorded on gritt.io was in April 2021.
When was QurCan Therapeutics Inc. founded?
QurCan Therapeutics Inc. was founded in 2018.
What industry is QurCan Therapeutics Inc. in?
QurCan Therapeutics Inc. operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is QurCan Therapeutics Inc. based?
QurCan Therapeutics Inc. is headquartered in Toronto, Canada.